Navigation Links
Quanta BioSciences qRT-PCR technology recommended in newly published CDC protocol for detection of H7N9 Avian Influenza
Date:4/25/2013

GAITHERSBURG, Md., April 25, 2013 /PRNewswire/ -- Quanta BioSciences today announced the CDC Real-Time RT-PCR (rRT-PCR) Protocol LP-152 for Detection and Characterization of Avian A/H7 (Eurasian-lineage) Influenza recommends that public health and other qualified laboratories utilize Quanta's qScript One-Step qRT-PCR Kit, Low ROX (95059-200 and 95059-050).

According to the World Health Organization (WHO) 108 cases of H7N9 influenza have been reported in China, causing severe respiratory illness including 22 deaths, as of April 23. Whether person-to-person transmission of this virus is possible is unclear, but other strains of Avian Influenza A, such as H5N1, have been spread via human-to-human interaction. With the potential threat of pandemic presented by any flu virus that can spread human-to-human, it is imperative that the best technologies are employed to detect and characterize these viruses.

In an effort to make supply of the qScript One-Step qRT-PCR technology available across the globe in reaction to the H7N9 outbreak, Quanta BioSciences has engaged its worldwide distribution network to ensure steady supply. For more information on this technology or to determine how to source these kits, please visit http://www.quantabio.com/avianflu.

About Quanta Biosciences:

Quanta BioSciences Inc., a U.S. based company, supplies superior quality reagents for demanding RT and PCR applications in life science, drug discovery and public health laboratories around the world. The Quanta BioSciences PCR and cDNA synthesis reagent portfolio defines the standard for reproducibility, specificity and sensitivity in the quantitative PCR market. The qScript technology named in CDC protocol LP-152 is part of a large family of polymerases designed and built for robust quantitative amplification and detection.

Media Contact: Will Geist , Quanta BioSciences, +1 800-364-2149, ext. 702 or email will.geist@quantabio.com 


'/>"/>
SOURCE Quanta BioSciences
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Quantason Names Dr. Ellen B. Mendelson, Medical Director
2. Centrillion Biosciences Announces Next-Gen Sequencing Innovation Grant Program
3. Sangamo BioSciences Announces Presentation At The Needham Healthcare Conference
4. Sangamo BioSciences Announces Presentation At Regen Med Investor Day
5. Further Advancements Made in the Development of an Improved Method For Rape Kit Testing Using Pressure BioSciences Patented Pressure Cycling Technology (PCT)
6. Northstar Biosciences Launches All Natural Skincare Solutions
7. New Applications of Pressure BioSciences PCT Platform Prominently Featured at Scientific Conference on Technologies for Protein Research
8. INVENT Ventures and Heliant Ventures Seek to Accelerate Personalized Medicine Research, Co-Invest in Sanguine BioSciences
9. INVENT Ventures and Heliant Ventures Seek to Accelerate Personalized Medicine Research with Seed Round Investment in Sanguine BioSciences
10. Ambit Biosciences Files Registration Statement for Proposed Initial Public Offering
11. Nano3D Biosciences Releases 96-well BioAssembler for 3D Cell Culture
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... February 24, 2017 , ... ... be safely completed in an ambulatory surgery center (ASC) with satisfactory clinical and ... previous two-year TDR studies. , Jake Lubinski, president of AxioMed, commented on ...
(Date:2/24/2017)... Tenn. , Feb. 24, 2017 ... ("Provectus" or the "Company"), a clinical-stage oncology and ... regarding the deadline to participate in its previously ... units, consisting of shares of common stock and ... and holders of listed warrants. ...
(Date:2/24/2017)... , Feb. 24, 2017  Driven by ... biotechnology are now the fastest growing categories, finds ... Specialty Actives in Personal Care: Multi-regional Market Analysis ... and management consulting firm Kline. "Biotechnology ... that make them more effective for skin and ...
(Date:2/24/2017)... China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" ... in China, today announced its financial results for the fourth ... Quarter 2016 Financial Highlights Total sales ... RMB terms, or increased by 13.6% in USD terms to ... 2015. Gross profit increased by 13.3% to ...
Breaking Biology Technology:
(Date:2/14/2017)...  Wake Forest Baptist Medical Center today announced Julie Ann ... officer (CEO). Freischlag joins the medical center on May ... M.D., who last year announced that he would transition ... leading it since 2008.   As CEO, ... Baptist,s academic health system, which includes Wake Forest School ...
(Date:2/13/2017)... Former 9/11 Commission border counsel and Special Counsel to ... of Identity Strategy Partners, LLP, today releases the following ... Protecting the Nation From Foreign Terrorist Entry Into the ... Trump,s ,Travel Ban, Executive Order gains more notoriety and ... ban, it is important that our national discourse regain ...
(Date:2/9/2017)... 9, 2017 The biomass boiler market report ... biomass boiler market globally in terms of revenue (US$ ... The market for biomass boilers has been segmented on ... and country/region. The market based on feedstock type, has ... biogas & energy crops, urban residues, and others. On ...
Breaking Biology News(10 mins):